WASHINGTON–(BUSINESS WIRE)–The Consumer Healthcare Products Association (CHPA), the trade
association representing the leading manufacturers and marketers of
over-the-counter (OTC) medicines, released the following statement today
in support of a Delaware law prohibiting the sale of OTC medicines
containing the cough suppressant dextromethorphan (DXM) to minors.
Delaware is the twelfth state to pass a law addressing the issue of
cough medicine abuse among teens.
“CHPA thanks Governor Jack Markell for signing the bill into law and
Representative David Bentz and Senator Nicole Poore for shepherding the
bill through the legislative process,” CHPA President and CEO Scott
“CHPA has long supported state efforts to curb teen OTC cough medicine
abuse and has worked to increase parental awareness through its StopMedicineAbuse.org
campaign. This bill will further allow parents to prevent abuse among
teens, while continuing to ensure access for the millions of adults and
families who responsibly use products containing DXM to relieve common
According to the 2015 National Institute on Drug Abuse’s (NIDA’s) annual
Monitoring the Future survey, one in 30 teens abuses OTC cough medicine
containing DXM to get high. To learn more about the side effects of DXM
abuse and to obtain access to toolkits, brochures, and other educational
materials for parents and community leaders, visit StopMedicineAbuse.org.
The Consumer Healthcare Products Association (CHPA) is the
135-year-old trade association representing the leading manufacturers
and marketers of over-the-counter (OTC) medicines and dietary
supplements. Every dollar spent by consumers on OTC medicines saves the
U.S. healthcare system $6-$7, contributing a total of $102 billion in
savings each year. CHPA is committed to promoting the increasingly vital
role of over-the-counter medicines and dietary supplements in America’s
healthcare system through science, education, and advocacy.
Consumer Healthcare Products Association (CHPA)